Treating breast cancer with progesterone could aid survival

breast cancer
Micrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumour beyond the lymph node. Credit: Nephron/Wikipedia

A special technique where breast cancer cells are "rescued" for research has been developed at the University of Adelaide. Coupled with advanced scientific technologies pioneered by Cambridge University this has provided a unique insight into the hormone regulation of breast cancers, which is expected to lead to new treatments for the disease.

Published today in the journal, Nature, an international team discovered how receptors that mediate activity of the female sex hormones (estrogen and progesterone) interact with DNA to control the growth of a large majority of breast cancers.

Researchers at the University of Adelaide's Dame Roma Mitchell Cancer Research Laboratories, led by Professor Wayne Tilley, developed the new technique.

"One in eight Australian women will be diagnosed with breast cancer in their lifetime and seven women die from the disease each day in Australia," says Professor Tilley.

"Traditionally, breast cancer tumours are destroyed once they have been removed from a patient. The new technique we have developed sees tumour cells from participating patients 'rescued' for research purposes.

"This technique, which is used to test current and new forms of therapy on tumour cells, has potential to one day provide an individualised treatment option for the patient based on how the tumour responds to therapy.

"The method is also a vital research tool. It has helped shed light on the mystery of progesterone action that has confounded researchers and clinicians for a long time," he says

Dr Jason Carroll, from the University of Cambridge's Cancer Research UK Cambridge Institute, says they have discovered why patients with a particular type of hormone-driven breast cancer tend to have a better chance of recovery.

"We used state-of-the-art DNA reading technology to create maps showing where the attaches to DNA to switch on genes," says Dr Carroll. "We then compared these maps in grown with and without progesterone. This revealed how the 'switched on' redirects the oestrogen receptor to different DNA regions - switching on a different set of genes that slow down cell growth.

"This important research helps explain why some patients have a better prognosis. Crucially, it has provided a strong case for a clinical trial to investigate the potential benefit of adding to drugs that target the oestrogen receptor, which could improve treatment for the majority of hormone-driven breast cancers," he says.

Explore further

Smoking may impact survival after a breast cancer diagnosis

More information: Nature, DOI: 10.1038/nature14583
Journal information: Nature

Citation: Treating breast cancer with progesterone could aid survival (2015, July 8) retrieved 16 June 2021 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments